Azenta, Inc. is a leading pharmaceutical company in the United States, with a low risk ESG score of 15.9. Specializing in life sciences solutions, Azenta, Inc. helps bring impactful breakthroughs and therapies to market faster. The company offers reliable cold-chain sample management solutions and genomic services for drug development, clinical research, and advanced cell therapies. With two reportable segments - Life Sciences Products and Life Sciences Services, Azenta, Inc. serves top pharmaceutical, biotech, academic, and healthcare institutions worldwide.